Factors Related with Hospital Attendance and Mortality in Patients with COPD: A Case–Control Study in a Real-Life Setting

References

• Soriano JB, Kendrick PJ, Paulson KR, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585–596. doi:10.1016/S2213-2600(20)30105-3
   PubMed Web of Science ®Google Scholar
• Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1223–1249. doi:10.1016/S0140-6736(20)30752-2
   PubMed Web of Science ®Google Scholar
• Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–773. doi:10.1016/S0140-6736(07)61380-4
   PubMed Web of Science ®Google Scholar
• Ruano-Ravina A, Cameselle-Lago C, Torres-Durán M, et al. Indoor radon exposure and COPD, synergic association? a multicentric, hospital-based case–control study in a radon-prone area. Arch Bronconeumol. 2021;57(10):630–636. doi:10.1016/J.ARBRES.2020.11.015
   PubMed Web of Science ®Google Scholar
• Miravitlles M. Drug treatment of acute infective exacerbations of COPD. Arch Bronconeumol. 2007;43(SUPPL.4):18–26. doi:10.1016/s0300-2896(07)74006-1
   Google Scholar
• Soler JJ, Sánchez L, Latorre M, Alamar J, Román P, Perpiñá M. Impacto asistencial hospitalario de la EPOC. Peso específico del paciente con EPOC de alto consumo sanitario [The impact of COPD hospital resources: the specific burden of COPD patients with high rates of hospitalization]. Arch Bronconeumol. 2001;37(9):375–381. Spanish. doi:10.1016/S0300-2896(01)78818-7
   PubMed Web of Science ®Google Scholar
• Ancochea J. Estrategia en EPOC del SNS [Spanish National Health System COPD strategy]; 2010. Available from: http://www.msssi.gob.es/organizacion/sns/planCalidadSNS/pdf/ActualizacionEstrategiaCancer.pdf. Accessed April 8, 2022. Spanish.
   Google Scholar
• Librero J, Ibañez-Beroiz B, Peiró S, et al. Trends and area variations in potentially preventable admissions for COPD in Spain (2002-2013): a significant decline and convergence between areas. BMC Health Serv Res. 2016;16(1). doi:10.1186/s12913-016-1624-y
   PubMed Web of Science ®Google Scholar
• Pozo-Rodríguez F, López-Campos JL, Álvarez-martínez CJ, et al. Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study. PLoS One. 2012;7(7):e42156. doi:10.1371/JOURNAL.PONE.0042156
   PubMed Web of Science ®Google Scholar
• Shah T, Churpek MM, Perraillon MC, Konetzka RT. Understanding why patients with COPD get readmitted: a large national study to delineate the medicare population for the readmissions penalty expansion. Chest. 2015;147(5):1219–1226. doi:10.1378/chest.14-2181
   PubMed Web of Science ®Google Scholar
• Guerrero M, Crisafulli E, Liapikou A, et al. Readmission for acute exacerbation within 30 days of discharge is associated with a subsequent progressive increase in mortality risk in COPD patients: a long-term observational study. PLoS One. 2016;11(3):e0150737. doi:10.1371/JOURNAL.PONE.0150737
   PubMed Web of Science ®Google Scholar
• Celli BR, Decramer M, Wedzicha JA, et al. An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(7):e4–e27. doi:10.1164/rccm.201501-0044ST
   PubMed Web of Science ®Google Scholar
• Escarrabill J, Torrente E, Esquinas C, et al. Auditoría clínica de los pacientes que ingresan en el hospital por agudización de EPOC. Estudio MAG-1 [Clinical audit of patients hospitalized due to COPD exacerbation. MAG-1 study]. Arch Bronconeumol. 2015;51(10):483–489. Spanish. doi:10.1016/J.ARBRES.2014.06.023
   PubMed Web of Science ®Google Scholar
• Harries TH, Thornton H, Crichton S, Schofield P, Gilkes A, White PT. Hospital readmissions for COPD: a retrospective longitudinal study. NPJ Prim Care Respir Med. 2017;27(1):31. doi:10.1038/S41533-017-0028-8
   PubMed Web of Science ®Google Scholar
• Cerezo Lajas A, Rodríguez Jimeno E, Gallo González V, Oliva Ramos A, Puente Maestu L, Miguel Díez de J. Mortalidad y factores asociados al reingreso en los pacientes dados de alta por una exacerbación aguda de EPOC [Mortality and associated factors with readmission in patients discharged by acute exacerbation of COPD]. Rev patol respir. 2018;21:79–85. Spanish.
   Google Scholar
• Bafadhel M, Criner G, Dransfield MT, et al. Exacerbations of chronic obstructive pulmonary disease: time to rename. Lancet Respir Med. 2020;8(2):133–135. doi:10.1016/S2213-2600(19
   PubMed Web of Science ®Google Scholar
• Ställberg B, Janson C, Larsson K, et al. Real-world retrospective cohort study Arctic shows burden of comorbidities in Swedish COPD versus non-COPD patients. NPJ Prim Care Respir Med. 2018;28(1). doi:10.1038/s41533-018-0101-y
   PubMed Web of Science ®Google Scholar
• Lajas AC, Madrigal IB, Puente Maestu L, De J, Díez M. Ansiedad y depresión en pacientes ingresados por una exacerbación de EPOC [Anxiety and depression in patients admitted for COPD exacerbation]. Rev Patol Respir. 2020;23(4):134–140. Spanish.
   Google Scholar
• Fernández-García S, Represas-Represas C, Ruano-Raviña A, Mosteiro-Añón M, Mouronte-Roibas C, Fernández-Villar A. Social profile of patients admitted for COPD exacerbations. A gender analysis. Arch Bronconeumol. 2020;56(2):84–89. doi:10.1016/J.ARBRES.2019.03.009
   PubMed Web of Science ®Google Scholar
• Almagro P, Cabrera FJ, Diez-Manglano J, et al. Comorbidome and short-term prognosis in hospitalised COPD patients: the ESMI study. Eur Respir J. 2015;46(3):850–853. doi:10.1183/09031936.00008015
   PubMed Web of Science ®Google Scholar
• Mascaró Cavaller O, Serra Batlles J, Roura Poch PLDG.Estudio EPOC. Clasificación fenotípica y comorbilidades de una población hospitalaria [COPD study: phenotypic classification and comorbidities in a hospital population]. Med Respir. 2017;10(2):49–57. Spanish.
   Google Scholar
• Lajas AC, Puente Maestu L, De J, Díez M. Revista de patología respiratoria [Relevance of co-morbidities in COPD]. Rev Patol Respir.2019;22(3):81-83. Spanish
   Google Scholar
• Vos T, Lim SS, Abbafati Cet al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–1222. doi:10.1016/S0140-6736(20
   PubMed Web of Science ®Google Scholar
• Ferrone M, Masciantonio MG, Malus N, et al. The impact of integrated disease management in high-risk COPD patients in primary care. NPJ Prim Care Respir Med. 2019;29(1):1–9. doi:10.1038/s41533-019-0119-9
   PubMed Web of Science ®Google Scholar
• Braman SS. Hospital readmissions for COPD: we can meet the challenge. J Chronic Obstr Pulm Dis Found. 2015;2(1):4. doi:10.15326/JCOPDF.2.1.2015.0130
   PubMedGoogle Scholar
• Guía Española de la Enfermedad Pulmonar Obstructiva Crónica (GesEPOC) - GuíaSalud [Spanish COPD guidelines (GesEPOC): Pharmacological treatment of stable COPD]. Available from: https://portal.guiasalud.es/gpc/epoc/. Accessed August 15, 2021. Spanish.
   Google Scholar
• Fuertes Goñi MC, Carracedo E, Lorda A, Arillo Crespo A, Gómez AR, Martinez Vera MJ. Intervención con pacientes hiperfrecuentadores persistentes en atención primaria [Intervention with persistent hyperfrequent visiting patients in primary care]. Med Gen. 2017;6(1):3. Spanish.
   Google Scholar
• González-Peredo R, Prieto-Salceda MD, Campos-Caubet L, Fernández-Díaz F, García-Lago-Sierra Á, Incera-Alvear IM.  Perfil del usuario de un servicio de urgencias hospitalarias [Characteristics of hospital emergency department users]. Hiperfrecuentación. Med Gener Fam Semergen. 2018;44(8):537–548. Spanish. doi:10.1016/j.semerg.2018.05.009
   Google Scholar